Over 98 mn Indians will suffer from Type-2 diabetes by 2030: Study
While
Type-2
diabetes is expected to rise by more than a fifth, from 406 million in
2018 to 511 million in 2030 globally, India along with China and the US will
share over half of these high blood
sugar cases, say researchers led by one of an Indian-origin, while
asserting the need to improve access for the life saving insulin.
The
study, published in The Lancet
Diabetes and Endocrinology journal, showed that China (130 million)
followed by India (98 million), and the US (32 million) will constitute over half
of Type-2 diabetics by 2030.
As
a result, the amount of insulin needed to effectively treat Type-2 diabetes
will rise by more than 20 per cent worldwide over the next 12 years.
Compared
to current levels of insulin access, if universal global access was achieved
(with a treatment target of HbA1c -- measure of blood glucose) seven per cent
or lower, the number of people with Type-2 diabetes worldwide using insulin in
2030 would double from around 38 million (7.4 per cent of all people with
Type-2 diabetes) to 79 million (15.5 per cent), the researchers said. Read
Complete Article
Comments
Post a Comment